BR112012012811A2 - metodo de intensificar a sintese de proteina no musculo - Google Patents

metodo de intensificar a sintese de proteina no musculo

Info

Publication number
BR112012012811A2
BR112012012811A2 BR112012012811A BR112012012811A BR112012012811A2 BR 112012012811 A2 BR112012012811 A2 BR 112012012811A2 BR 112012012811 A BR112012012811 A BR 112012012811A BR 112012012811 A BR112012012811 A BR 112012012811A BR 112012012811 A2 BR112012012811 A2 BR 112012012811A2
Authority
BR
Brazil
Prior art keywords
protein synthesis
muscle
minutes
enhancing protein
relates
Prior art date
Application number
BR112012012811A
Other languages
English (en)
Portuguese (pt)
Inventor
Daniel Ryan Moore
Eric Zaltas
John Alan Hawley
Louise Mary Burke
Trent Stellingwerff
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BR112012012811A2 publication Critical patent/BR112012012811A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pediatric Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BR112012012811A 2009-11-29 2010-11-29 metodo de intensificar a sintese de proteina no musculo BR112012012811A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09177423.2A EP2327316B1 (en) 2009-11-29 2009-11-29 Method of enhancing muscle protein synthesis
PCT/EP2010/068439 WO2011064373A1 (en) 2009-11-29 2010-11-29 Method of enhancing muscle protein synthesis

Publications (1)

Publication Number Publication Date
BR112012012811A2 true BR112012012811A2 (pt) 2015-09-15

Family

ID=42135915

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012012811A BR112012012811A2 (pt) 2009-11-29 2010-11-29 metodo de intensificar a sintese de proteina no musculo

Country Status (13)

Country Link
US (1) US20130203645A1 (https=)
EP (1) EP2327316B1 (https=)
JP (1) JP5810429B2 (https=)
CN (1) CN102665445B (https=)
AU (1) AU2010323089B2 (https=)
BR (1) BR112012012811A2 (https=)
CA (1) CA2781764A1 (https=)
IN (1) IN2012DN04085A (https=)
MX (1) MX2012005646A (https=)
NZ (1) NZ600094A (https=)
PH (1) PH12012500875A1 (https=)
RU (1) RU2503269C1 (https=)
WO (1) WO2011064373A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150150898A1 (en) * 2012-06-11 2015-06-04 Nu Science Laboratories, Inc. Nutritional products and methods of improving exercise performance and reducing exercise induced impairment of immune function
US10016472B2 (en) 2012-06-11 2018-07-10 William J. Kraemer Methods of mitigating the negative effects of resistance exercise
WO2014081884A1 (en) * 2012-11-20 2014-05-30 Pronutria, Inc. Engineered secreted proteins and methods
US9820504B2 (en) 2013-03-08 2017-11-21 Axiom Foods, Inc. Rice protein supplement and methods of use thereof
AU2014225786B2 (en) 2013-03-08 2017-10-12 Axiom Foods, Inc. Rice protein supplements
CN105246357A (zh) * 2013-03-26 2016-01-13 普瑞米尔营养公司 提高组合训练后肌肉蛋白质合成的方法
US10271570B2 (en) 2013-08-15 2019-04-30 Nu Science Laboratories, Inc. Compositions for and methods of diet supplementation
WO2015040533A1 (en) * 2013-09-19 2015-03-26 Premier Nutrition Corporation Methods for enhancing muscle protein synthesis during energy deficit
PL238958B1 (pl) * 2016-06-29 2021-10-25 Olimp Laboratories Spolka Z Ograniczona Odpowiedzialnoscia Kompozycja aminokwasowa do stosowania przed wysiłkiem fizycznym
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
WO2018209131A1 (en) 2017-05-12 2018-11-15 Axiom Foods, Inc. Rice products and systems and methods for making thereof
IL296055A (en) 2017-08-14 2022-10-01 Axcella Health Inc Amino acid compositions for the treatment of liver disease
MA52971A (fr) 2018-06-20 2021-04-28 Axcella Health Inc Compositions et procédés pour le traitement de l'infiltration de graisse dans le muscle

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997043912A1 (en) * 1996-05-23 1997-11-27 Otsuka Pharmaceutical Co., Ltd. Food composition for lowering body fat content and improving body composition and method therefor
US6013290A (en) * 1997-11-17 2000-01-11 Weinstein; Robert E. Assemblage of nutrient beverages and regimen for enhancing convenience, instruction, and compliance with exercise supplementation
US6051236A (en) * 1998-11-12 2000-04-18 Pacifichealth Laboratories, Inc. Composition for optimizing muscle performance during exercise
EP1112693B1 (en) * 1999-12-30 2006-03-22 Kerry Group Services Ltd Composition comprising carbohydrate and peptide material and its use as an energy supplement after or during physical exercise or as a metabolic nutrient for oral consumption
WO2002047612A2 (en) * 2000-10-27 2002-06-20 Mannatech, Inc. Dietary supplement compositions
US7740893B2 (en) * 2001-04-02 2010-06-22 Mott's Llp Sports drink composition for enhancing glucose uptake into the muscle and extending endurance during physical exercise
US20030064134A1 (en) * 2001-10-03 2003-04-03 Eastman Outdoors Kit, system and method for preparing home-made nutritional food items
US7288570B2 (en) * 2002-12-20 2007-10-30 Nutricia N.V. Stimulation of in vivo production of proteins
JP2005070853A (ja) * 2003-08-26 2005-03-17 Md 21:Kk ダイエットプログラムのメニュー作成方法及びそのシステム
US7205018B2 (en) * 2004-10-07 2007-04-17 Next Proteins, Inc. Carbonated protein drink and method of making
WO2007006135A1 (en) * 2005-07-07 2007-01-18 H3 Formulations Ltd. Dietary supplement for enhancing skeletal muscle mass, decreasing muscle protein degradation, downregulation of muscle catabolism pathways, and decreasing catabolism of muscle cells
WO2007056176A2 (en) * 2005-11-03 2007-05-18 Southwest Immunology, Inc. Compositions for preventing and reducing delayed onset muscle soreness
US20070243290A1 (en) * 2006-04-18 2007-10-18 Melody Thompson Method of tailoring infant formulas to individual nutritional needs prior to use
US20070270355A1 (en) * 2006-05-11 2007-11-22 Garcia Ramon D Sport drink containing amino acids and carbohydrates
RU2306720C1 (ru) * 2006-07-06 2007-09-27 Энвер Саидович Токаев Продукт "спортамин" для питания спортсменов
US20090169684A1 (en) * 2007-12-29 2009-07-02 Cresta Andrea K Fitness and exercise enhancing tablet containing protein isolate
EP2098126A1 (en) * 2008-03-03 2009-09-09 Nestec S.A. Carbohydrate Bar

Also Published As

Publication number Publication date
US20130203645A1 (en) 2013-08-08
WO2011064373A1 (en) 2011-06-03
JP5810429B2 (ja) 2015-11-11
JP2013511970A (ja) 2013-04-11
CN102665445B (zh) 2015-03-25
AU2010323089B2 (en) 2014-07-24
MX2012005646A (es) 2012-06-13
AU2010323089A1 (en) 2012-05-31
IN2012DN04085A (https=) 2015-08-07
EP2327316B1 (en) 2016-11-16
RU2503269C1 (ru) 2014-01-10
EP2327316A1 (en) 2011-06-01
CA2781764A1 (en) 2011-06-03
PH12012500875A1 (en) 2013-01-07
NZ600094A (en) 2014-10-31
CN102665445A (zh) 2012-09-12
HK1175664A1 (en) 2013-07-12

Similar Documents

Publication Publication Date Title
BR112012012811A2 (pt) metodo de intensificar a sintese de proteina no musculo
WO2012081982A3 (en) Whey protein composition with a reduced astringency
BR112015024757A2 (pt) métodos para aprimorar síntese de proteína muscular seguindo treinamento simultâneo
BR112014007675A2 (pt) tratamento de doença articular degenerativa
MX2011010353A (es) Composicion farmaceutica.
NZ724593A (en) Anti-cd70 antibody drug conjugates
BR112013000446A2 (pt) composição nutricional para a estimulação de síntese de proteína muscular
BR112012033422A2 (pt) composições nutricionais de proteína alta, hipocalórica e métodos de usar as mesmas
BRPI0616982B8 (pt) uso de oligouronato, composição farmacêutica inalável e aplicador de spray
GT200600115A (es) Metodo para identificar blancos terapeuticos para el tratamiento de atrofia vulvoginal
BR112015032572A2 (pt) composições e métodos para melhorar o desempenho durante exercícios
CO2020004801A2 (es) Uso de suplementos de aminoácidos para mejorar la síntesis de proteínas musculares
BRPI0720230A2 (pt) Uso de uma formulação nutricional oralmente administrável, formulação nutricional, método para tratar um distúrbio desenvolvimental penetrante, e, composição
MX2013006094A (es) Metodo para inhibir patogenos usando composicion nutricional.
MX2010001381A (es) Genes y proteinas de brachyspira hyodysenteriae y usos de los mismos.
RU2015153242A (ru) Действующее вещество для лечения саркопении
BRPI0512503A (pt) composição que compreende ácido lático e lactoferrina
MX2011007108A (es) Incrementadores de angiogenesis generados por derrame cerebral y usos de los mismos.
ATE551067T1 (de) Tumstatin zur behandlung von erkrankungen die mit der neumodellierung von atemwegsgewebe zusammenhängen
DE602008004556D1 (de) Zusammensetzungen und verfahren zum nachweis von störungen in verbindung mit histamin
WO2007107323A3 (en) Novel genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy
MX349837B (es) Composicion de transglutaminasa seca.
TW200718783A (en) Novel genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy
EP2271664A4 (en) NEW SEQUENCES OF BRACHYSPIRA, IMMUNOGENIC COMPOSITION, METHOD OF MANUFACTURE AND APPLICATION THEREOF
WO2014045065A3 (en) Dietary compositions and their uses

Legal Events

Date Code Title Description
B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A23L 1/305 , A23L 1/29 , A23L 1/30

Ipc: A23L 33/18 (2016.01), A23L 2/66 (1995.01), A23L 29

Ipc: A23L 33/18 (2016.01), A23L 2/66 (1995.01), A23L 29

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]